Risk Ratio [RR] = 0.92, 95%CI = 0.860.99, respectively) ( Unstable angina pectoris: An umbrella review of meta-analyses of RCTs including 56,004 patients with diabetes, prediabetes, and at high risk of diabetes, found no association between GLP-1 RAs and the risk of uAP (RR = 1.06, 95%CI = 0.931.21) when compared to placebo ( Coronary Revascularization Procedures Trials including LEADER, AMPLITUDE-O, and REWIND found no effect of GLP-1 RAs on the risk of coronary revascularization ( p = 0.46) included 9,901 individuals with T2DM ( Chronic Coronary Syndromes, Vasospastic and Microvascular Angina Existing evidence on the role of GLP-1 RAs on CCS and vasospastic and microvascular angina is scarce
[9] This is linked to the thin-fat phenotype common in South Asians: relatively higher body fat around the abdomen and lower muscle mass even at a "normal" weight
Possible Orlistat side effects include gas, increased bowel movements, and fecal incontinence
While this new class of drugs, called GLP-1 receptor agonist drugs, are approved for use in diabetes and for weight loss, researchers have found that they might help with other conditions too, like cardiovascular disease and addiction
Other filings allege motility disorders that can present like an intestinal blockage, including ileus-type symptoms and other severe complications requiring hospitalization
